Patents by Inventor Sebastien Daver

Sebastien Daver has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for synthesizing enantiomerically pure N-(pyridin-4-yl)-2-hydroxy-alkylamide derivatives
    Patent number: 10343999
    Abstract: The present invention relates to a novel process for preparing enantiomerically pure compounds of N-(pyrid-4-yl)-2-hydroxyalkylamide type corresponding to the general formula (C) below: and also to processes for preparing the reaction intermediates used in this synthesis, said intermediates having the general formulae (A) and (B) below:
    Type: Grant
    Filed: November 8, 2016
    Date of Patent: July 9, 2019
    Assignee: Galderma Research & Development
    Inventors: Jean-Guy Boiteau, Sebastien Daver, Nicolas Rodeville
  • METHOD FOR SYNTHESIZING ENANIOMERICALLY PURE N-(PYRIDIN-4-YL)-2-HYDROXY-ALKYLAMIDE DERIVATIVES
    Publication number: 20190010124
    Abstract: The present invention relates to a novel process for preparing enantiomerically pure compounds of N-(pyrid-4-yl)-2-hydroxyalkylamide type corresponding to the general formula (C) below: and also to processes for preparing the reaction intermediates used in this synthesis, said intermediates having the general formulae (A) and (B) below:
    Type: Application
    Filed: November 8, 2016
    Publication date: January 10, 2019
    Applicant: Galderma Research & Development
    Inventors: Jean-Guy BOITEAU, Sébastien DAVER, Nicolas RODEVILLE
  • Ligands that modulate RAR receptors
    Patent number: 8470871
    Abstract: Novel ligand compounds having the general formula (I): and pharmaceutical/cosmetic compositions comprised thereof are useful in human and veterinary medicine or, alternatively, in cosmetics.
    Type: Grant
    Filed: June 19, 2012
    Date of Patent: June 25, 2013
    Assignee: Galderma Research & Development
    Inventors: Thibaud Biadatti, Laurence Dumais, Catherine Soulet, Sandrine Talano, Sebastien Daver
  • NOVEL LIGANDS THAT MODULATE RAR RECEPTORS
    Publication number: 20120258996
    Abstract: Novel ligand compounds having the general formula (I): and pharmaceutical/cosmetic compositions comprised thereof are useful in human and veterinary medicine or, alternatively, in cosmetics.
    Type: Application
    Filed: June 19, 2012
    Publication date: October 11, 2012
    Applicant: Galderma Research & Development
    Inventors: Thibaud BIADATTI, Laurence DUMAIS, Catherine SOULET, Sandrine TALANO, Sebastien DAVER
  • Ligands that modulate RAR receptors
    Patent number: 8227507
    Abstract: Novel ligand compounds having the general formula (I): and pharmaceutical/cosmetic compositions comprised thereof are useful in human and veterinary medicine or, alternatively, in cosmetics.
    Type: Grant
    Filed: July 23, 2010
    Date of Patent: July 24, 2012
    Assignee: Galderma Research & Development
    Inventors: Thibaud Biadatti, Laurence Dumais, Catherine Soulet, Sandrine Talano, Sebastien Daver
  • NOVEL LIGANDS THAT MODULATE RAR RECEPTORS
    Publication number: 20100292296
    Abstract: Novel ligand compounds having the general formula (I): and pharmaceutical/cosmetic compositions comprised thereof are useful in human and veterinary medicine or, alternatively, in cosmetics.
    Type: Application
    Filed: July 23, 2010
    Publication date: November 18, 2010
    Applicant: Galderma Research & Development
    Inventors: Thibaud BIADATTI, Laurence Dumais, Catherine Soulet, Sandrine Talano, Sebastien Daver
  • Ligands that modulate RAR receptors and pharmaceutical/cosmetic compositions comprised thereof
    Patent number: 7807708
    Abstract: Novel ligand compounds having the general formula (I): and pharmaceutical/cosmetic compositions comprised thereof are useful in human and veterinary medicine or, alternatively, in cosmetics.
    Type: Grant
    Filed: June 25, 2007
    Date of Patent: October 5, 2010
    Assignee: Galderma Research & Development
    Inventors: Thibaud Biadatti, Laurence Dumais, Catherine Soulet, Sandrine Talano, Sebastien Daver
  • Preparation of 3-[5?-(3,4-bis(hydroxymethyl)benzyloxy)-2?-ethyl-2-propylbiphenyl-4-yl]pentan-3-ol
    Patent number: 7638657
    Abstract: 3-[5?-(3,4-bis(hydroxymethyl)benzyloxy)-2?-ethyl-2-propylbiphenyl-4-yl]pentan-3-ol is prepared from the novel intermediate, 6-ethyl-4?-(1-ethyl-1-hydroxypropyl)-2?-propylbiphenyl-3-ol.
    Type: Grant
    Filed: May 18, 2007
    Date of Patent: December 29, 2009
    Assignee: Galderma Research & Development
    Inventors: Eric Terranova, Sebastien Daver, Christine Marty, Jean-Claude Pascal
  • Novel ligands that modulate RAR receptors and pharmaceutical/cosmetic compositions comprised thereof
    Publication number: 20080015246
    Abstract: Novel ligand compounds having the general formula (I): and pharmaceutical/cosmetic compositions comprised thereof are useful in human and veterinary medicine or, alternatively, in cosmetics.
    Type: Application
    Filed: June 25, 2007
    Publication date: January 17, 2008
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Thibaud Biadatti, Laurence Dumais, Catherine Soulet, Sandrine Talano, Sebastien Daver
  • Preparation of 3-[5'-(3,4-bis(hydroxymethyl)benzyloxy)-2'-ethyl-2-propylbiphenyl-4-yl]pentan-3-ol
    Publication number: 20070282136
    Abstract: 3-[5?-(3,4-bis(hydroxymethyl)benzyloxy)-2?-ethyl-2-propylbiphenyl-4-yl]pentan-3-ol is prepared from the novel intermediate, 6-ethyl-4?-(1-ethyl-1-hydroxypropyl)-2?-propylbiphenyl-3-ol
    Type: Application
    Filed: May 18, 2007
    Publication date: December 6, 2007
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Eric Terranova, Sebastien Daver, Christine Marty, Jean-Claude Pascal